TASIGNA for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where TASIGNA was used for Neoplasm malignant.
Most Reported Side Effects for TASIGNA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 76 | 9.8% | 76 | 6 |
| Fatigue | 67 | 8.7% | 3 | 6 |
| Rash | 53 | 6.9% | 0 | 5 |
| Nausea | 42 | 5.4% | 2 | 7 |
| Dyspnoea | 37 | 4.8% | 6 | 15 |
| Headache | 31 | 4.0% | 0 | 6 |
| Chronic myeloid leukaemia | 30 | 3.9% | 16 | 8 |
| Malignant neoplasm progression | 28 | 3.6% | 17 | 5 |
| Anaemia | 27 | 3.5% | 6 | 9 |
| Electrocardiogram qt prolonged | 27 | 3.5% | 0 | 4 |
| Pruritus | 27 | 3.5% | 0 | 3 |
| Diarrhoea | 26 | 3.4% | 0 | 3 |
| Myocardial infarction | 25 | 3.2% | 5 | 13 |
| Chest pain | 23 | 3.0% | 1 | 13 |
| Alopecia | 22 | 2.9% | 0 | 0 |
Other Indications for TASIGNA
Chronic myeloid leukaemia (562)
Off label use (21)
Acute lymphocytic leukaemia (10)
Leukaemia (9)
Gastrointestinal stromal tumour (8)
Product used for unknown indication (6)
Acute myeloid leukaemia (5)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)